Lihong Wang                          
     
phone:17766076315office hours：                                                            
fax：                                                               homepageURL：                                                              
office location：                                                               email：lw2247@yeah.net                                                              
address：                                                              
Research Fields

1、The mechanism of noncoding RNA in breast cancer.

2、Identification of drug resistance molecular markers in cancer


Honor Reward

1、Third prize in Scientificand TechnologicalAwards of ChineseAnti-Cancer Association

2、Heilongjiangprovincial Science and Technology Progress Award

3、First prize ofScience and Technology Award in the University of Heilongjiang province

4、First prize ofAcademic achievement award in Harbin Natural Science and Technology


Academic Achievements

1、Lihong Wang*, Tian Luan, Shunheng Zhou, Jing Lin, Yue Yang, Wei Liu, Xiao Tong, Wei Jiang*. LncRNA HCP5 promotes triple negative breast cancer     progression as a ceRNA to regulate BIRC3 by sponging miR‐219a‐5p. Cancer medicine. 2019 May26; 8(9):4389-4403.

2、Leiming Jiang, Xuexin Yu, Xueyan Ma, Haizhou Liu, Shunheng Zhou, Xu Zhou, Qianqian Meng, Lihong Wang*, Wei Jiang*. Identification of transcriptionfactor-miRNA-lncRNA feed-forward loops in breast cancer subtypes.Computational Biology and Chemistry 2018.11.008.

3、Shunheng Zhou†, Lihong Wang†,Qian Yang, Haizhou Liu, Qianqian Meng, Leiming Jiang, Shuyuan Wang, Wei Jiang*. Systematicalanalysis of lncRNA-mRNA competing endogenous RNA network in breast cancersubtypes. Breast Cancer Research and Treatment 2018 Jun;169(2):267-275.

4、TianLuan, Ximei Zhang, Shuyuan Wang, Jing Lin, Weiwei An, Weiguang Yuan, HuilongCai, Qingyuan Zhang*, Lihong Wang*. Long non-coding RNA MIAT promotes breast cancerprogression and functions as ceRNA to regulate DUSP7 expression by spongingmiR-155. Oncotarget. 2017 Jul 12;8(44):76153-76164.

5、Jing Lin, Wei Liu, Tian Luan,Lili Yuan, Wei Jiang, Huilong Cai, Weiguang Yuan, Yuwen Wang, Qingyuan Zhang*, Lihong Wang*. High expression of PU.1 is correlation with Her-2 and shortersurvival in breast cancer patients. Oncology Letters. 2017 14: 8220-8226.

6、Weisha Liu, Shuyuan Wang,Shunheng Zhou, Feng Yang, Wei Jiang, Qingyuan Zhang*, LihongWang*. A systems biologyapproach to identify microRNAs contributing to cisplatin resistance in humanovarian cancer cells. Mol Biosyst. 2017 Oct24;13(11):2268-2276.

7、EnyuDai, Feng Yang,Jing Wang,Xu Zhou, Qian Song, Weiwei An, Lihong Wang*, Wei Jiang*. ncDR: a comprehensive resource of non-coding RNAs involved in drug resistance. Bioinformatics. 2017 Dec15;33(24):4010-4011.

8、Liu Xinyi, Feng Dongfei, Liu Dianming, Wang Shuyuan, Yu Xuexin, DaiEenyu, Wang Jing, Wang Lihong*,Jiang Wei*. Dissecting the Origin of Breast Cancer Subtype Stem Cell and thePotential Mechanism of Malignant Transformation. PLoS One. 2016 Oct21;11(10):e0165001.

9、Ximei Zhang†, Lihong Wang†, Dongju Su, Dan Zhu, Qiuming Li, Meihua Chi. MicroRNA-29b promotesthe adipogenic differentitation of human adipose tisse-derived stromal cells.Obesity 2016; 24(5):1097-105.

10、Yan Zhang, DianmingLiu, Lihong Wang, Shuyuan Wang, Xuexin Yu, Enyu Dai, Xinyi Liu, Sanshun Luo*, Wei Jiang*. Integrated systems approachidentifies risk regulatory pathways and key regulators in coronary arterydisease. J Mol Med (Berl).2015 Dec;93(12):1381-90.